CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Phase Ia study of Atezolizumab (NCT01375842) monotherapy in relapsed endometrial cancer were reported as abstract at ASCO 2017. Fif...
Phase 3
Berlin, Germany and 92 other locations
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Berlin, Germany and 66 other locations
for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...
Phase 3
Berlin, Germany and 76 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Berlin, Germany and 168 other locations
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...
Phase 2
Berlin, Germany and 92 other locations
This is a Phase I, FIH, open-label, multicenter, dose escalation trial with expansion cohorts to evaluate safety and preliminary efficacy of claudin...
Phase 1
Berlin, Germany and 11 other locations
Amendment 5 is to obtain additional safety experience at the newly defined recommended Phase 2 dose of 500 mg every 4 weeks in patients with endometrial...
Phase 1
Berlin, Germany and 79 other locations
does to the body besides treating the disease.Participants will have cancer that has spread in the body near where it started (locally advan...
Phase 1
Berlin, Other, Germany and 17 other locations
Prospective, open-label, dose-ranging, uncontrolled phase I/II study of Lurbinectedin in combination with irinotecan. The study will be divided into...
Phase 1, Phase 2
Berlin, Germany and 21 other locations
progression-free survival in participants with cervical cancer....
Phase 2
Berlin, Germany and 71 other locations
Clinical trials
Research sites
Resources
Legal